In the last years, a significant advance in the field of respiratory stem cell biology has occurred. However, there is still little knowledge about the regulation of lung stem cell behaviour by the niche and further investigation is required. Understanding the interactions between lung stem cells and their niche as well as studying how changes in the local microenvironment affect stem cell behaviour, will contribute to comprehend the development of disease and to discover novel therapeutic approaches.
The aging field encompasses a wide range of biology, involving many model organisms and, with respect to mammals, the involvement of many tissues. In addition, translational strategies to modify the rate of aging range from lifestyle change to drugs and, more recently stem cell-based therapeutics. As such, there is an abiding need to bring together scientists across diverse fields with the purpose of providing a clear overview of the state of basic research in aging and the development of translational strategies. The goal is to create cross-fertilization between scientists in different areas, accelerating the development of interventions that extend human health span.
This conference will provide a unique forum for the research community, focusing on translational studies geared towards therapies in AD and related neurodegenerative diseases so they can come together to discuss the latest advances and the future challenges in the field.
The second Carbon Dioxide Conversion Catalysis (CDCC-2) will bring together academic and industrial experts focusing on the catalytic conversion of carbon dioxide into value-added products. The conference will feature several relevant topics dealing with either heterogeneous, homogeneous or hybrid forms of catalytic solutions for the production of fine chemicals, pharmaceuticals, polymers and energy vectors.
Rather than discussing mainly structural aspects of the ubiquitin system, this conference is dedicated to the study of functional roles of the ubiquitin system, how it works to ensure normal signal transduction, what are the pathological consequences when it is perturbed and how can we harness our knowledge of the ubiquitin system therapeutically for more efficacious treatment of diseases with high unmet clinical need, including cancer, chronic inflammatory and autoimmune disorders as well as neurodegenerative diseases.
We'll keep in touch with you on a quarterly basis! Sharing our forthcoming conference calendar, bringing you all the latest Fusion related news as well as deadline reminders and grant opportunities for our live and virtual meetings.
All personal data herein are processed in accordance with UK data protection legislation. By signing up to receive marketing communications, you give consent for our processing. You may withdraw this consent at any time by writing to us.
If you're wondering how a Fusion Online conference works, here's a brief overview to familiarise yourself with our platform. It has been designed and built by us, tailored specifically to meet the needs of academic conferences.Find out more